Randomized Controlled Trial of Combined Letrozole and Clomid (CLC II) Versus Letrozole Alone for Women With Anovulation
Status:
Recruiting
Trial end date:
2023-12-01
Target enrollment:
Participant gender:
Summary
This study evaluates the addition of clomiphene citrate (CC) to letrozole for the treatment
of infertility in women with polycystic ovary syndrome across a course of two treatment
cycles with stair step dosing of letrozole similar to standard of care. Half of the
participants will receive letrozole and CC in combination, while the other half will receive
letrozole alone.
Phase:
Phase 4
Details
Lead Sponsor:
Rachel Mejia
Collaborators:
American Society for Reproductive Medicine Society for Reproductive Investigation University of Wisconsin, Madison